5VT1
Crystal Structure of the Human CAMKK2B bound to a thiadiazinone benzamide inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I03 |
Synchrotron site | Diamond |
Beamline | I03 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-01-25 |
Detector | DECTRIS PILATUS3 S 6M |
Wavelength(s) | 0.9763 |
Spacegroup name | P 61 |
Unit cell lengths | 100.454, 100.454, 69.674 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 19.960 - 1.900 |
R-factor | 0.162 |
Rwork | 0.161 |
R-free | 0.18500 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2zv2 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.030 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.3) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 19.960 | 1.940 |
High resolution limit [Å] | 1.900 | 1.900 |
Rmerge | 0.140 | 0.575 |
Rpim | 0.066 | 0.275 |
Number of reflections | 31197 | 2111 |
<I/σ(I)> | 7.3 | |
Completeness [%] | 98.7 | 99.7 |
Redundancy | 5.1 | 5.2 |
CC(1/2) | 0.988 | 0.836 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 293 | 24% PEG 8000, 0.1M magnesium acetate, 0.1M CHC buffer (citric acid, ches, hepes). |